Andrea Liapis Jackson - 09 Jun 2022 Form 4/A - Amendment Insider Report for Codex DNA, Inc. (TBIO)

Role: Director
Signature: /s/ Jennifer McNealey, as Attorney-in-Fact
Issuer symbol: TBIO
Transactions as of: 09 Jun 2022
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 15 Jun 2022, 16:35:17 UTC
Date Of Original Report: 13 Jun 2022
Previous filing: 17 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TBIO	Common Stock						0	09 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TBIO	Stock Option (right to buy)						0	09 Jun 2022	Common Stock	0		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 9, 2022, the Reporting Person was granted 20,630 restricted stock units and options to purchase 30,945 shares of common stock of Codex DNA, Inc. (the "Issuer") under the Issuer's Outside Director Compensation Policy. However, the Reporting Person has declined the awards described above and any future annual awards until further notice. As a result, the transfer of such restricted stock units and options to purchase common stock did not in fact take place. Accordingly, as of June 15, 2022, the Reporting Person did not own any restricted stock units or options to purchase shares of common stock in the Issuer.

Content

On June 9, 2022, the Reporting Person was granted 20,630 restricted stock units and options to purchase 30,945 shares of common stock of Codex DNA, Inc. (the "Issuer") under the Issuer's Outside Director Compensation Policy. However, the Reporting Person has declined the awards described above and any future annual awards until further notice. As a result, the transfer of such restricted stock units and options to purchase common stock did not in fact take place. Accordingly, as of June 15, 2022, the Reporting Person did not own any restricted stock units or options to purchase shares of common stock in the Issuer.